| 英文摘要 |
Yolk sac tumor (YST) is a rare and aggressive subtype of nonseminomatous germ cell tumor with a poor prognosis. This case report presents the successful treatment of a primary mediastinal YST in a 19-year-old male. The tumor, located in the anterior mediastinum and surrounding structures, measured 17 cm in diameter and caused persistent dry cough and dyspnea. It had invaded the chest wall, the left lower lobe of the lung, and the pericardium. The integrated treatment approach included radiotherapy, modified chemotherapy with bleomycin, etoposide, and cisplatin, followed by surgical excision. During the first chemotherapy cycle, the patient experienced an immediate hypersensitivity reaction to etoposide, characterized by facial erythema and general discomfort. After intravenous fluid resuscitation, the infusion rate of etoposide was reduced by half to maintain chemotherapy efficacy. Serum levels ofα-fetoprotein (AFP) and lactate dehydrogenase (LDH) decreased significantly after chemotherapy. Despite complications such as neutropenia and postoperative nausea, the tumor shrank and was subsequently removed via debulking surgery. Intraoperatively, tumor invasion into the left phrenic nerve was observed. Pathological examination revealed necrosis and fibrous adhesion in the resected tumor, with no residual tumor cells detected. No postoperative complications were reported, and no tumor recurrence was observed during a five-year follow-up. The favorable outcome in this case supports the efficacy of the integrated treatment protocol and highlights the importance of adapting chemotherapy regimens to manage hypersensitivity reactions effectively. |